已收盤 11-14 16:00:00 美东时间
-5.090
-5.74%
Nebius shares are trading lower Friday afternoon, continuing a volatile week triggered by mixed Q3 earnings and concerns over shareholder dilution.
11-15 05:28
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
TradingKey - Nebius, a cloud service provider focused on AI infrastructure, released its Q3 2025 earnings before market open on November 11. Despite announcing a new $3 billion order with Meta, the stock plunged over 7% that day due to weaker-than-expected results, and has since fallen nearly 20%.
11-14 10:40
迪士尼绩后重挫8%!股价创近半年新低;明星科技股走弱,特斯拉大跌5%,Palantir跌超4%;AI云概念延续跌势,CoreWeave跌6%>>
11-13 23:27
华盛资讯11月13日讯,Nebius Group N.V.公司今日公布2025财年Q3业绩,公司Q3营收1.46亿美元,同比增长355.1%,股权持有人应占亏损1.20亿美元,同比亏损扩大27.0%。
11-13 20:17
Our analysis explores whether Nebius stock's sharp rally has real substance, or if the cycle hints at trouble ahead.
11-13 19:50
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从12美元升至15美元;Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至107美元
11-13 09:58
Northland Capital Markets analyst Nehal Chokshi maintains Nebius Group (NASDAQ:NBIS) with a Outperform and raises the price target from $206 to $211.
11-13 02:06
Shares of Nebius Group N.V. (NASDAQ: NBIS) are trading lower Wednesday after the company reported mixed third-quarter results.
11-13 01:31
The latest announcement is out from Nebius Group ( ($NBIS) ). On November 12, 2...
11-13 00:28